Physician profile
Eric R Ratner
NPI 1083677819
$3,624.09
in general payments reported to CMS, 2019-2025
19 companies · $24.83 in 2025
The $24.83 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $592 · 2021: $543 · 2022: $824 · 2023: $787 · 2024: $355 · 2025: $24.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128 · Debt Forgiveness: $38.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.82 |
| Debt Forgiveness | $38.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,764.85 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $769.45 | 2019-2024 | Proclaim |
| Medtronic, INC. | $237.30 | 2021-2022 | |
| Medtronic USA, INC. | $129.07 | 2019-2020 | |
| Si-Bone, INC. | $120.74 | 2021 | |
| Merz North America, INC. | $115.69 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $103.34 | 2022-2023 | Seglentis |
| Relievant Medsystems, INC. | $101.46 | 2021-2022 | |
| Optinose US, INC. | $48.49 | 2019-2022 | |
| Baxter Healthcare | $38.71 | 2023 | |
| Nevro Corp. | $31.28 | 2019-2024 | Senza |
| International Rehabilitative Sciences, INC | $27.62 | 2023 | Rs 4i Plus Sequential Stimulator |
| Vertos Medical, INC. | $25.22 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $24.87 | 2024 | |
| Scilex Pharmaceuticals INC. | $23.16 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $18.43 | 2024 | Painteq |
| Abbvie INC. | $17.90 | 2022 | |
| Horizon Therapeutics Plc | $13.67 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Ratner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.